Resources and guidance for supporting employees, customers, and partners during this unprecedented health crisis.

  • October 22, 2020

Embracing the Future of Decentralized Trials and Remote Visits for Site Staff and Patients

Katherine Vandebelt
Global Head of Clinical Innovation
This is a syndicated post, view the original post here

The pandemic has created disruptions across every aspect of daily life, with clinical trials being no exception. But instead of impeding clinical research, the pandemic has created opportunities to refresh the way clinical trials are performed and has helped us discover how we can make patients’ lives easier by using new approaches and innovation.

So, what capabilities and technologies do site staff and patients need for decentralized clinical trials?

In episode eight of The Latest Dose, our host Kathy Vandebelt invites Casey Orvin, senior vice president of pharmaceutics relationships at StudyKIK and honorary president of the Society for Clinical Research Sites (SCRS) to talk about the future of decentralized trials and remote visits from the patient and site perspective. In this discussion, Kathy and Casey examine the diversity of the site and patient community, how current trends like patient-centric trials are empowering the site landscape, and how the pandemic has helped shape the future of how patient-facing devices are used, decentralized clinical trials are conducted, and remote visits take place.

You can listen to the whole conversation by tuning into The Latest Dose.


Visit The Latest Dose to listen to our other episodes. Don’t forget to subscribe and look out for our next podcast!

Be the first to comment

Comments ( 0 )
Please enter your name.Please provide a valid email address.Please enter a comment.CAPTCHA challenge response provided was incorrect. Please try again.